Document is current
Any future updates will be listed below
-
Authors
Vitillo, Loriana https://orcid.org/0000-0002-7184-1793
Durance, Catherine
Hewitt, Zoe
Moore, Harry
Smith, Austin
Vallier, Ludovic
-
Funding
Funding for this research was provided by:
Medical Research Council
Biotechnology and Biological Sciences Research Council
Engineering and Physical Sciences Research Council
- License Information
-
More Information
Article History
Received: 18 May 2020
Revised: 21 August 2020
Accepted: 31 August 2020
First Online: 18 September 2020
Ethics approval and consent to participate
: Derivation of the MasterShef-3, -4, -7, -8, -10 and -11 cell lines was performed in the Stem Cell Derivation Facility at the Centre for Stem Cell Biology, University of Sheffield, under the Human Fertilisation and Embryology Authority (HFEA) licence R0115-8-A (Centre 0191) and Human Tissue Authority (HTA) licence 22510, in a clean room setting, following strict standard operating procedures. All experiments were performed in accordance with the relevant guidelines and regulations. The embryos used to derive MasterShef-3, -4, -7, 10 (frozen embryos) and MasterShef-8 and -11 (fresh embryos) were donated from different assisted conception units, following fully informed consent, with no financial benefit to the donors, and were surplus or unsuitable for their IVF treatment.
: Not applicable.
: The authors declare that they have no competing interests.
